Clinical Trials Browser

Phase 2 × Octreotide × 1 year × Clear all

NCT06865677 2026-01-21

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Phase 2 Terminated

2 enrolled 7 charts

Recurrence

NCT06326190 2025-09-16

LUMEN-1

Phase 2 Recruiting

Meningioma